Aigan Co., Ltd. (9854) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With a growth in Net Sales of 5.2%, the company declared Very Positive results in Jun 25

NET PROFIT(HY) Higher at JPY 0.26 MM
ROCE(HY) Highest at 0.52%
RAW MATERIAL COST(Y) Fallen by -0.25% (YoY)

With ROE of 0.36%, it has a expensive valuation with a 0.27 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 4,447 Million (Micro Cap)

P/E

74.00

Industry P/E

Dividend Yield

0.47%

Debt Equity

-0.33

Return on Equity

1.06%

Price to Book

0.37

Revenue and Profits:

Net Sales:

3,744 Million

(Quarterly Results - Jun 2025)

Net Profit:

-101 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

1.5%

6 Months

35.33%

1 Year

40.97%

2 Years

13.41%

3 Years

17.34%

4 Years

12.78%

5 Years

-13.25%

Aigan Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-0.74%

EBIT Growth (5y)

-219.29%

EBIT to Interest (avg)

-366.40

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.36

Sales to Capital Employed (avg)

1.21

Tax Ratio

96.91%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

0.07%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.27

EV to EBIT

8.72

EV to EBITDA

-21.89

EV to Capital Employed

-0.14

EV to Sales

-0.08

PEG Ratio

0.57

Dividend Yield

0.66%

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

0.36%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 5.20% vs -2.79% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -260.32% vs 6,200.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,744.00",
          "val2": "3,559.00",
          "chgp": "5.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-47.00",
          "val2": "9.00",
          "chgp": "-622.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-55.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-101.00",
          "val2": "63.00",
          "chgp": "-260.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-23.20%",
          "val2": "-11.50%",
          "chgp": "-1.17%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 1.40% vs 3.24% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 101.66% vs 77.46% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14,863.00",
          "val2": "14,658.00",
          "chgp": "1.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "51.00",
          "val2": "63.00",
          "chgp": "-19.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-88.00",
          "val2": "-35.00",
          "chgp": "-151.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.00",
          "val2": "-181.00",
          "chgp": "101.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-8.60%",
          "val2": "-8.40%",
          "chgp": "-0.02%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

3,744.00

3,559.00

5.20%

Operating Profit (PBDIT) excl Other Income

-47.00

9.00

-622.22%

Interest

0.00

Exceptional Items

0.00

-55.00

100.00%

Consolidate Net Profit

-101.00

63.00

-260.32%

Operating Profit Margin (Excl OI)

-23.20%

-11.50%

-1.17%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 5.20% vs -2.79% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -260.32% vs 6,200.00% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

14,863.00

14,658.00

1.40%

Operating Profit (PBDIT) excl Other Income

51.00

63.00

-19.05%

Interest

0.00

Exceptional Items

-88.00

-35.00

-151.43%

Consolidate Net Profit

3.00

-181.00

101.66%

Operating Profit Margin (Excl OI)

-8.60%

-8.40%

-0.02%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 1.40% vs 3.24% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 101.66% vs 77.46% in Mar 2024

All Annual Results

Company CV

About Aigan Co., Ltd.

Aigan Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available